EU drug regulator says unusual blood clot is 'very rare Oxford-AstraZeneca vaccine side effect'
The European Union's medicines regulator says unusual blood clots should be listed as a very rare side effect of the Oxford-AstraZeneca COVID-19 vaccine. After a study